Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period

Journal of Hospital Medicine

Volumn 3, Issue 4, 2008, Pages 319-325

  Rosenman, David J ^a   McDonald, Furman S ^a   Ebbert, Jon O ^a   Erwin, Patricia J ^a,b   LaBella, Matthew ^c   Montori, Victor M ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

ACE I; Anesthesia; Angiotensin receptor blocker; Anglotensin converting enzyme inhibitor; ARA; ARB; Outcomes; Perioperative; Preoperative

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYPERTENSIVE FACTOR;

ANESTHESIA INDUCTION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG USE; HEART INFARCTION; HOSPITAL CARE; HUMAN; HYPERTENSION; HYPOTENSION; LONG TERM CARE; META ANALYSIS; PATIENT CARE; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT WITHDRAWAL;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; HUMANS; HYPOTENSION; MYOCARDIAL INFARCTION; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 51549085617     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.323     Document Type: Review

References (17)

1. Guyatt G, Montori V, Devereaux PJ, Schunemann H, Bhandari M. Patients at the center: in our practice, and in our use of language. ACP J Club. 2004;140:A11-A12.
2. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet. 1999;354:1896-1900.
3. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Ottawa Health Research Institute, University of Ottawa, Ontario, Canada. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Accessed: March 21, 2006.
4. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. Sep 1986;7:177-188.
5. Michael J. Sweeting AJS, Paul C. Lambert. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004;23:1351-1375.
6. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
7. Altman DG, Bland JM. Statistics notes: Interaction revisited: the difference between two estimates BMJ. 2003;326:219
8. Coriat P, Richer C, Douraki T, et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology. 1994;81:299-307.
9. Comfere T, Sprung J, Kumar MM, et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg. 2005;100:636-644.
10. Brabant SM, Bertrand M, Eyraud D, Darmon PL, Coriat P. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg. 1999;89:1388-1392.
11. Bertrand M, Godet G, Meersschaert K, Brun L, Salcedo E, Coriat P. Should the angiotensin II antagonists be discontinued before surgery2 [see comment]. Anesth Analg. 2001;92:26-30.
12. Zipes. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 7th ed. New York: Saunders, an imprint of Elsevier; 2005.
13. Montori V, Guyatt G. Summarizing the Evidence: Publication Bias. Chicago: AMA Press; 2002.
14. Cappelleri JC, Ioannidis JP, Schmid CH, et al. Large trials vs meta-analysis of smaller trials: how do their results compare? [see comment]. JAMA. 1996;276:1332-1338.
15. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
16. Fleisher LA. Preoperative evaluation of the patient with hypertension. JAMA. 2002;287:2043-2046.
17. Pigott DW, Nagle C, Allman K, Westaby S, Evans RD. Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements. Br J Anaesth. 1999;83:715-720.